MRC1 and melanoma: Thus, our data from the in vivo B16-F10 and CT26 murine tumor models are consistent with our findings using in vitro–generated CD206+ human TAM and with the expression profiles from melanoma patient specimens, described above, further confirming the capabilities of CD206+ TAM as a potent Ag–cross-presenting cell population in the tumor microenvironment.